IRWD vs AYTU โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IRWD Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ironwood Pharmaceuticals, Inc. - Class A (IRWD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while AYTU counters with relative strength in Valuation. Fundamentally, IRWD trades at 12.3x Forward P/E with 62.9% operating margin (+9.0% YoY revenue) versus AYTU at 9.2x Forward P/E and -14.4% operating margin (+6.4% YoY). In options structure, IRWD sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | IRWD Revenue | AYTU Revenue | IRWD Op. Margin | AYTU Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $430M | $10M | 28.0% | -230.1% | IRWD |
| FY2020 | $390M | $30M | 36.7% | -76.5% | IRWD |
| FY2021 | $410M | $70M | 56.1% | -89.7% | IRWD |
| FY2022 | $410M | $100M | 61.0% | -113.7% | IRWD |
| FY2023 | $440M | $110M | -213.5% | -15.9% | AYTU |
| FY2024 | $350M | $70M | 26.5% | -2.4% | IRWD |
| FY2025 | $300M | $70M | 33.3% | -11.8% | IRWD |
| FY2026 | N/A | $60M | N/A | -14.4% | AYTU |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IRWD | AYTU | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $802.9M | $19.6M | Larger Scale | IRWD |
| Trailing P/E Ratio Valuation | 5.4x | 9.2x | Lower Multiple | IRWD |
| Forward P/E Ratio Valuation | 12.3x | 9.2x | Lower Multiple | AYTU |
| Revenue Growth (YoY) Growth | +9.0% | +6.4% | Higher Growth | IRWD |
| Operating Margin (TTM) Profitability | 62.9% | -14.4% | Higher Margin | IRWD |
| Net Profit Margin Profitability | 37.4% | -24.8% | Higher Margin | IRWD |
| Return on Equity (ROE) Capital Efficiency | -574.7% | -52.5% | Higher ROE | AYTU |
| 52-Week Range Position Momentum | 68% ($3โ$6) | 5% ($2โ$3) | Stronger Trend | IRWD |
| Beta / 30D Volatility Risk Regime | 1.37ฮฒ ยท 54% Vol | 0.65ฮฒ ยท 35% Vol | Lower Realized Risk | AYTU |
| Unified Institutional Score Composite Signal | 34.8 / 100 (SELL) | 48.9 / 100 (HOLD) | Higher Composite | AYTU |